IMI PBM Cryogenic Fire Rated Valve 2-way
Experience safety and performance with the IMI PBM Cryogenic Fire Rated 2-way Valve, engineered to the highest standards to manage flammable media in the most demanding environments. This Valve is part of the renowned Igenix® Series 6, designed specifically for applications requiring sanitary processing and stringent fire safety measures.
The Valve boasts a range of impressive features. It is thoroughly tested and certified to API-607 standards, ensuring superior fire safety performance. Made from high-quality materials like 316L stainless steel (ASTM A351 CF3M), Hastelloy® C276, and other ASME B16.34 listed materials, it offers robustness under various operational conditions. The advanced design includes a three-piece "swing-out" body that facilitates thorough cleaning and complete draining. It features upstream and downstream bubble-tight sealing capabilities and a True-Bore® design that ensures the port internal diameter (ID) is consistent with system tubing for unimpeded flow. The Valve is also free of animal-derived ingredients (ADIs), offers surface finishes of up to 20 Ra ID, and is available in mechanical and electropolished finishes. It can handle pressures up to 720 psig and temperatures up to 450°F, depending on the seat and seal material. Additionally, the Valve includes customizable options for end connections, such as extended tubes, hygienic clamps, and compression ends to meet specific system requirements.
Safety features of the Valve include a Spring Return Handle with an optional fusible link that activates at a pre-set temperature, automatically closing the Valve in fire conditions to prevent further hazards. The Valve is also automation-ready, with direct mount automation capabilities for easy integration into automated systems.
Additional options for the IMI PBM Cryogenic Fire Rated Valve include equipping it with a 'Direct Mount' spring return pneumatic actuator for automated operations. There is also the possibility for customization with specific materials and end fittings available upon request to ensure compatibility with specific industrial applications. This combination of features makes the IMI PBM Cryogenic Fire Rated 2-way Valve a reliable and essential component for industries requiring stringent safety and sanitary measures.
- Sizes Available: 1/2" to 3"
- Body Seals: Incorporates FDA-approved elastomer or encapsulated elastomer options with FDA-compliant TFM™ material for seats and seals.
- End Fittings: Matches tubing connections for seamless integration, available in configurations as orbital weld ends with controlled sulfur content.
- Stem Packing: Live-loaded with white TFM, graphite body gaskets, and packing isolated from process media under normal conditions.
Related Products
At Liquidyne, we prioritize our commitment to quality and consistency. In 2017 we achieved ISO 9001:2015 Quality Management System certification to ensure we can repeatedly deliver consistently high-quality products and solutions. Being ISO 9001:2015 QMS Certified by Orion Registrar, Inc, together with our USP Class VI Testing, ASME Bioprocessing Equipment (BPE), and EHEDG certification guarantee, we have the methodologies to assure quality. We will quickly and accurately rectify any issues if any of our products are ever in non-conformance.
"Thanks so much! What a quick turn around. It is a pleasure working with Liquidyne."
Process Development Manager
"I received the cart yesterday, thanks for the fast delivery! It feels sturdy. I sat on it. It does not bounce. It is also easy to clean and wipe or wash down."
Vice President, Analytical Development and Manufacturing
"Thanks again for reacting so quickly and meeting me halfway with the element. We will be able to get installed and have things keep moving overnight with the night crew. The little things like this are always greatly appreciated when working with Liquidyne."
Chemical Engineer
“This pump cut our processing time from 3 days to 1 shift. I’m not giving this pump back. You will have to come and get it if you want it... and that won’t likely happen.”
VP Antibody Manufacturing